{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:30:47Z","timestamp":1760189447890},"reference-count":15,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":15,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1111\/dth.12271","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T07:03:09Z","timestamp":1439794989000},"page":"369-372","source":"Crossref","is-referenced-by-count":4,"title":["Anti-tumour necrosis factor treatment of severe psoriasis complicated by Epstein-Barr Virus hepatitis and subsequently by chronic hepatitis"],"prefix":"10.1155","volume":"28","author":[{"given":"Petra","family":"Cetkovska","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical Faculty and Teaching Hospital Pilsen; Charles University; Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Lomicova","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical Faculty and Teaching Hospital Pilsen; Charles University; Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Mukensnabl","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical Faculty and Teaching Hospital Pilsen; Charles University; Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloysius C.M.","family":"Kroes","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology; Leiden University Medical Center; Leiden The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"10.1111\/dth.12271-BIB0001|dth12271-cit-0001","first-page":"340","article-title":"Managing comorbid disease in patients with psoriasis","volume":"15","author":"Boehncke","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/dth.12271-BIB0002|dth12271-cit-0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","article-title":"Tumor necrosis factor blockade and the risk of viral infection","volume":"6","author":"Kim","year":"2010","journal-title":"Nature reviews. Rheumatology"},{"key":"10.1111\/dth.12271-BIB0003|dth12271-cit-0003","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12876-014-0214-x","article-title":"Lack of evidence of viral reativation in HbsAg-negative HbcAB-positive and HCV patients undergoing immunosuppressive therapy for psoriasis","volume":"14","author":"Morisco","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/dth.12271-BIB0004|dth12271-cit-0004","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1684\/ejd.2011.1318","article-title":"Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients","volume":"21","author":"Zanni","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1111\/dth.12271-BIB0005|dth12271-cit-0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjd.12045","article-title":"Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting","volume":"168","author":"Navarro","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12271-BIB0006|dth12271-cit-0006","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2340\/00015555-0619","article-title":"Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis","volume":"89","author":"Kluger","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/dth.12271-BIB0007|dth12271-cit-0007","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2009.02.029","article-title":"Autoimmune hepatitis in two psoriasis patients treated with infliximab","volume":"63","author":"Goujon","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12271-BIB0008|dth12271-cit-0008","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000354593","article-title":"Hepatitis and lupus-like syndrome during infliximab therapy for Psoriasis","volume":"5","author":"Riad","year":"2013","journal-title":"Case Rep Dermatol"},{"key":"10.1111\/dth.12271-BIB0009|dth12271-cit-0009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: A comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J Autoimmunity"},{"key":"10.1111\/dth.12271-BIB0010|dth12271-cit-0010","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/hep.23834","article-title":"Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor \u03b1 agents","volume":"2","author":"Efe","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/dth.12271-BIB0011|dth12271-cit-0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2010.07.016","article-title":"Epstein Barr virus hepatitis","volume":"22","author":"Kofteridis","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1111\/dth.12271-BIB0012|dth12271-cit-0012","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2036.2012.05122.x","article-title":"Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis","volume":"36","author":"Vine","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/dth.12271-BIB0013|dth12271-cit-0013","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(95)91438-2","article-title":"Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals","volume":"346","author":"Vento","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/dth.12271-BIB0014|dth12271-cit-0014","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/0961203314527367","article-title":"Chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis exacerbation in a patient with systemic lupus erythematosus","volume":"23","author":"Yamashita","year":"2014","journal-title":"Lupus"},{"key":"10.1111\/dth.12271-BIB0015|dth12271-cit-0015","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.22783","article-title":"Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase Epstein-Barr virus load in patients with rheumatoid arthritis","volume":"57","author":"Balandraud","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12271","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12271\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:55:27Z","timestamp":1671818127000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12271"}},"subtitle":["Report on EBV hepatitis during infliximab therapy"],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12271","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,17]]}}}